BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12846763)

  • 1. Resource utilization among kidney transplant recipients.
    Khan S; Tighiouart H; Kalra A; Raman G; Rohrer RJ; Pereira BJ
    Kidney Int; 2003 Aug; 64(2):657-64. PubMed ID: 12846763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care utilization among patients with chronic kidney disease.
    Khan SS; Kazmi WH; Abichandani R; Tighiouart H; Pereira BJ; Kausz AT
    Kidney Int; 2002 Jul; 62(1):229-36. PubMed ID: 12081582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality after kidney transplant failure: the impact of non-immunologic factors.
    Gill JS; Abichandani R; Kausz AT; Pereira BJ
    Kidney Int; 2002 Nov; 62(5):1875-83. PubMed ID: 12371992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Outcomes of Parathyroidectomy in Kidney Transplant Recipients with Persistent Hyperparathyroidism.
    Tseng PY; Yang WC; Yang CY; Tarng DC
    Kidney Blood Press Res; 2015; 40(4):386-94. PubMed ID: 26184764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and outcome of pyelonephritis among renal transplant recipients.
    Graversen ME; Dalgaard LS; Jensen-Fangel S; Jespersen B; Østergaard L; Søgaard OS
    BMC Infect Dis; 2016 Jun; 16():264. PubMed ID: 27287058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States.
    Tveit DP; Hypolite I; Bucci J; Hshieh P; Cruess D; Agodoa LY; Welch PG; Abbott KC
    J Nephrol; 2001; 14(5):361-8. PubMed ID: 11730268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalizations for bacterial pneumonia after renal transplantation in the United States.
    Tveit DJ; Hypolite IO; Poropatich RK; Hshieh P; Cruess D; Hawkes CA; Agodoa LY; Abbott KC
    J Nephrol; 2002; 15(3):255-62. PubMed ID: 12113596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of posttransplant events in renal transplant recipients in Europe.
    Chamberlain G; Baboolal K; Bennett H; Pockett RD; McEwan P; Sabater J; Sennfält K
    Transplantation; 2014 Apr; 97(8):854-61. PubMed ID: 24732898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambient air pollutants and risk of fatal coronary heart disease among kidney transplant recipients.
    Spencer-Hwang R; Knutsen SF; Soret S; Ghamsary M; Beeson WL; Oda K; Shavlik D; Jaipaul N
    Am J Kidney Dis; 2011 Oct; 58(4):608-16. PubMed ID: 21778006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and consequences of acute kidney injury in kidney transplant recipients.
    Mehrotra A; Rose C; Pannu N; Gill J; Tonelli M; Gill JS
    Am J Kidney Dis; 2012 Apr; 59(4):558-65. PubMed ID: 22226565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium.
    Heldal K; Hartmann A; Leivestad T; Foss A; Midtvedt K
    Nephrol Dial Transplant; 2011 Aug; 26(8):2706-11. PubMed ID: 21285131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of major hemorrhage after kidney transplantation.
    Sood MM; Garg AX; Bota SE; Marisiddappa L; McArthur E; Naylor KL; Kapral MK; Kim SJ; Lam NN; Molnar AO; Harel Z; Perl J; Knoll GA
    Am J Nephrol; 2015; 41(1):73-80. PubMed ID: 25677869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival.
    Sagedal S; Hartmann A; Nordal KP; Osnes K; Leivestad T; Foss A; Degré M; Fauchald P; Rollag H
    Kidney Int; 2004 Jul; 66(1):329-37. PubMed ID: 15200441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic opioid analgesic usage post-kidney transplantation and clinical outcomes.
    Kulshrestha S; Barrantes F; Samaniego M; Luan FL
    Clin Transplant; 2014 Sep; 28(9):1041-6. PubMed ID: 24986478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalization risks related to vascular access type among incident US hemodialysis patients.
    Ng LJ; Chen F; Pisoni RL; Krishnan M; Mapes D; Keen M; Bradbury BD
    Nephrol Dial Transplant; 2011 Nov; 26(11):3659-66. PubMed ID: 21372255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital admissions and emergency department visits among kidney transplant recipients.
    Weeda ER; Su Z; Taber DJ; Bian J; Morinelli TA; Pilch NA; Mauldin PD; DuBay DA
    Clin Transplant; 2019 May; 33(5):e13522. PubMed ID: 30861180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
    Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
    J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.